Literature DB >> 24754656

Survival on dialysis among American Indians and Alaska Natives with diabetes in the United States, 1995-2010.

Nilka Ríos Burrows1, Pyone Cho, Kai McKeever Bullard, Andrew S Narva, Paul W Eggers.   

Abstract

OBJECTIVES: We assessed survival in American Indians and Alaska Natives (AI/ANs) with end-stage renal disease attributed to diabetes who initiated hemodialysis between 1995 and 2009.
METHODS: Follow-up extended from the first date of dialysis in the United States Renal Data System until December 31, 2010, kidney transplantation, or death. We used the Kaplan-Meier method to compute survival on dialysis by age and race/ethnicity and Cox regression analysis to compute adjusted hazard ratios (HRs).
RESULTS: Our study included 510,666 persons-48% Whites, 2% AI/AN persons, and 50% others. Median follow-up was 2.2 years (interquartile range = 1.1-4.1 years). At any age, AI/AN persons survived longer on hemodialysis than Whites; this finding persisted after adjusting for baseline differences. Among AI/AN individuals, those with full Indian blood ancestry had the lowest adjusted risk of death compared with Whites (HR = 0.58; 95% confidence interval = 0.55, 0.61). The risk increased with declining proportion of AI/AN ancestry.
CONCLUSIONS: Survival on dialysis was better among AI/AN than White persons with diabetes. Among AI/AN persons, the inverse relationship between risk of death and level of AI/AN ancestry suggested that cultural or hereditary factors played a role in survival.

Entities:  

Mesh:

Year:  2014        PMID: 24754656      PMCID: PMC4035878          DOI: 10.2105/AJPH.2014.301942

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  24 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Survival among Mexican-Americans, non-Hispanic whites, and African-Americans with end-stage renal disease: the emergence of a minority pattern of increased incidence and prolonged survival.

Authors:  J A Pugh; M R Tuley; S Basu
Journal:  Am J Kidney Dis       Date:  1994-06       Impact factor: 8.860

3.  The relationship of age, race, and ethnicity with survival in dialysis patients.

Authors:  Guofen Yan; Keith C Norris; Alison J Yu; Jennie Z Ma; Tom Greene; Wei Yu; Alfred K Cheung
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

4.  Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Mark J Sarnak; Hocine Tighiouart; Guruprasad Manjunath; Bonnie MacLeod; John Griffith; Deeb Salem; Andrew S Levey
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  The effect of racial misclassification on estimates of end-stage renal disease among American Indians and Alaska Natives in the Pacific Northwest, 1988 through 1990.

Authors:  J R Sugarman; L Lawson
Journal:  Am J Kidney Dis       Date:  1993-04       Impact factor: 8.860

7.  Differences in survival between black and white patients with diabetic end-stage renal disease.

Authors:  C C Cowie; F K Port; K F Rust; M I Harris
Journal:  Diabetes Care       Date:  1994-07       Impact factor: 19.112

8.  End state renal disease among Native Americans, 1983-86.

Authors:  J M Newman; A A Marfin; P W Eggers; S D Helgerson
Journal:  Am J Public Health       Date:  1990-03       Impact factor: 9.308

9.  Chronic kidney disease and cardiovascular disease in the Medicare population.

Authors:  Allan J Collins; Shuling Li; David T Gilbertson; Jiannong Liu; Shu-Cheng Chen; Charles A Herzog
Journal:  Kidney Int Suppl       Date:  2003-11       Impact factor: 10.545

10.  Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project.

Authors:  Diane L Frankenfield; Michael V Rocco; Sheila H Roman; William M McClellan
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  4 in total

Review 1.  The National Institute on Aging Health Disparities Research Framework.

Authors:  Carl V Hill; Eliseo J Pérez-Stable; Norman A Anderson; Marie A Bernard
Journal:  Ethn Dis       Date:  2015-08-07       Impact factor: 1.847

2.  Inequalities and outcomes: end stage kidney disease in ethnic minorities.

Authors:  Emma Wilkinson; Alison Brettle; Muhammad Waqar; Gurch Randhawa
Journal:  BMC Nephrol       Date:  2019-06-26       Impact factor: 2.388

3.  Patient and allograft outcomes after kidney transplant for the Indigenous patients in the United States.

Authors:  Regan Seipp; Nan Zhang; Sumi Sukumaran Nair; Hasan Khamash; Amit Sharma; Scott Leischow; Raymond Heilman; Mira T Keddis
Journal:  PLoS One       Date:  2021-02-03       Impact factor: 3.240

Review 4.  Epidemiology of haemodialysis outcomes.

Authors:  Aminu K Bello; Ikechi G Okpechi; Mohamed A Osman; Yeoungjee Cho; Htay Htay; Vivekanand Jha; Marina Wainstein; David W Johnson
Journal:  Nat Rev Nephrol       Date:  2022-02-22       Impact factor: 42.439

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.